Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Kaposi Sarcoma Market Portraiture
2.1.1. Global Kaposi Sarcoma Market, by Treatment Type, 2016
2.1.2. Global Kaposi Sarcoma Market, by Geography, 2016
Chapter 3. Kaposi Sarcoma: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Kaposi Sarcoma Market, by Treatment Type
4.3. Chemotherapy
4.3.1. Alkaloids
4.3.2. Liposomal Anthracyclines
4.4. Immunotherapy
4.5. Highly Active Antiretroviral Therapy (HAART)
4.6. Radiation Therapy
4.7. Surgical Procedures
Chapter 5. Global Kaposi Sarcoma Market, by Geography, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. North America Kaposi Sarcoma Market Analysis, 2015 – 2025
5.2.1. North America Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.2.2. North America Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Kaposi Sarcoma Market Analysis, 2015 – 2025
5.3.1. Europe Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.3.2. Europe Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. France
5.3.2.4. Rest of Europe
5.4. Asia Pacific Kaposi Sarcoma Market Analysis, 2015 – 2025
5.4.1. Asia Pacific Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.4.2. Asia Pacific Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. India
5.4.2.4. Rest of APAC
5.5. Latin America Kaposi Sarcoma Market Analysis, 2015 – 2025
5.5.1. Latin America Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.5.2. Latin America Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Kaposi Sarcoma Market Analysis, 2015 – 2025
5.6.1. MEA Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.6.2. MEA Kaposi Sarcoma Market, by Region, 2015 – 2025 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Aphios Corp.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Bristol Myers Squibb Company
6.3. Cytori Therapeutics, Inc.
6.4. CytRx Corporation
6.5. Eli Lilly and Co.
6.6. GlaxoSmithKline plc.
6.7. F.Hoffman La-Roche, Inc.
6.8. Johnson and Johnson
6.9. Merck & Co., Inc.
6.10. Pfizer, Inc.
6.11. Other Notable Players
List of Figures
FIG. 1 Kaposi Sarcoma: Market Segmentation
FIG. 2 Global Kaposi Sarcoma Market Share, by Treatment Type, 2016 (Value %)
FIG. 3 Global Kaposi Sarcoma Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Chemotherapy Market, 2015 – 2025 (US$ Mn)
FIG. 7 Global Alkaloids Market, 2015 – 2025 (US$ Mn)
FIG. 8 Global Liposomal Anthracyclines Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Immunotherapy Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global HAART Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Radiation Therapy Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Surgical Procedures Market, 2015 – 2025 (US$ Mn)
FIG. 13 U.S. Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 14 Canada Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 15 U.K. Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 16 Germany Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 17 France Kaposi Sarcoma Market, 2015-2025 (US$ Mn)
FIG. 18 Rest of Europe Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest of Asia Pacific Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest of Latin America Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
FIG. 27 Rest of Middle East and Africa Kaposi Sarcoma Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Kaposi Sarcoma Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 6 Mn)
TABLE 7 Europe Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 11 Latin America Kaposi Sarcoma Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East and Africa Kaposi Sarcoma Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Middle East and Africa Kaposi Sarcoma Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 14 Aphios Corp.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Bristol Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Cytori Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 CytRx Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Eli Lilly and Co.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 GlaxoSmithKline plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 F.Hoffman La-Roche, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Johnson and Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)